Form 4 for PHVS Pharvaris N.V.
Accepted 2026-04-24 11:27:11 ET · period of report 2026-04-22 · accession 0001193125-26-175965 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-04-24 11:27 | 2026-04-22+ | PHVS | Lu Peng | Chief Medical Off | M - OptEx | $2.59 | +7,101 | 66.2K | +12% | +$18.4K |
| DMT | 2026-04-24 11:27 | 2026-04-22+ | PHVS | Lu Peng | Chief Medical Off | S - Sale+OE | $30.05 | -7,101 | 66.1K | -10% | -$213.4K |
| DMT | 2026-04-24 11:27 | 2026-04-22+ | PHVS | Lu Peng | Chief Medical Off | M - OptEx | $0.00 | -7,101 | 106.2K | -6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-22 | M | A | 7,001 | $2.59 | 73,084 | D | — | — | (F1) This is a scheduled exercise and sale from 10b5-1 trading plan. |
| 2 | Common | Common Stock | 2026-04-22 | S | D | 7,001 | $30.05 | 66,083 | D | — | — | (F1) This is a scheduled exercise and sale from 10b5-1 trading plan. (F2) These shares were sold in multiple transactions at prices ranging from $30 - $30.15. |
| 3 | Common | Common Stock | 2026-04-23 | M | A | 100 | $2.59 | 66,183 | D | — | — | (F1) This is a scheduled exercise and sale from 10b5-1 trading plan. |
| 4 | Common | Common Stock | 2026-04-23 | S | D | 100 | $30.03 | 66,083 | D | — | — | (F1) This is a scheduled exercise and sale from 10b5-1 trading plan. (F3) These shares were sold in multiple transactions at prices ranging from $30.03 - $31.0299. |
| 5 | Derivative | Stock Option (Right to Buy) | 2026-04-22 | M | D | 7,001 | $0.00 | 106,307 | D | $2.59 · — to 2030-02-03 | 7,001 Common Stock | (F1) This is a scheduled exercise and sale from 10b5-1 trading plan. (F4) 25% of the option vested on February 3, 2020 with the remaining shares vesting in 1/48 monthly installments thereafter. |
| 6 | Derivative | Stock Option (Right to Buy) | 2026-04-23 | M | D | 100 | $0.00 | 106,207 | D | $2.59 · — to 2030-02-03 | 100 Common Stock | (F1) This is a scheduled exercise and sale from 10b5-1 trading plan. (F4) 25% of the option vested on February 3, 2020 with the remaining shares vesting in 1/48 monthly installments thereafter. |